EI
Ellevest Inc’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $737K | Sell |
19,201
-1,737
| -8% | -$66.7K | 0.12% | 128 |
|
|
2025
Q1 | $811K | Buy |
20,938
+7,140
| +52% | +$277K | 0.05% | 123 |
|
|
2024
Q4 | $467K | Sell |
13,798
-5,301
| -28% | -$179K | 0.03% | 210 |
|
|
2024
Q3 | $781K | Buy |
19,099
+1,137
| +6% | +$46.5K | 0.04% | 141 |
|
|
2024
Q2 | $692K | Buy |
17,962
+3,616
| +25% | +$139K | 0.04% | 151 |
|
|
2024
Q1 | $615K | Sell |
14,346
-1,211
| -8% | -$51.9K | 0.04% | 160 |
|
|
2023
Q4 | $577K | Buy |
15,557
+1,535
| +11% | +$56.9K | 0.04% | 158 |
|
|
2023
Q3 | $508K | Sell |
14,022
-1,190
| -8% | -$43.1K | 0.04% | 143 |
|
|
2023
Q2 | $542K | Sell |
15,212
-523
| -3% | -$18.6K | 0.04% | 140 |
|
|
2023
Q1 | $560K | Buy |
15,735
+3,204
| +26% | +$114K | 0.04% | 115 |
|
|
2022
Q4 | $440K | Buy |
12,531
+3,443
| +38% | +$121K | 0.04% | 146 |
|
|
2022
Q3 | $267K | Sell |
9,088
-6,742
| -43% | -$198K | 0.03% | 214 |
|
|
2022
Q2 | $689K | Buy |
15,830
+2,008
| +15% | +$87.4K | 0.06% | 72 |
|
|
2022
Q1 | $602K | Buy |
13,822
+2,129
| +18% | +$92.7K | 0.05% | 89 |
|
|
2021
Q4 | $516K | Buy |
11,693
+2,143
| +22% | +$94.6K | 0.05% | 100 |
|
|
2021
Q3 | $365K | Buy |
9,550
+7,277
| +320% | +$278K | 0.04% | 148 |
|
|
2021
Q2 | $91K | Buy |
2,273
+958
| +73% | +$38.4K | 0.01% | 381 |
|
|
2021
Q1 | $47K | Sell |
1,315
-4,177
| -76% | -$149K | 0.01% | 490 |
|
|
2020
Q4 | $202K | Sell |
5,492
-5,607
| -51% | -$206K | 0.03% | 166 |
|
|
2020
Q3 | $418K | Buy |
11,099
+489
| +5% | +$18.4K | 0.08% | 71 |
|
|
2020
Q2 | $433K | Buy |
10,610
+991
| +10% | +$40.4K | 0.09% | 53 |
|
|
2020
Q1 | $364K | Buy |
9,619
+8,514
| +770% | +$322K | 0.1% | 47 |
|
|
2019
Q4 | $52K | Buy |
1,105
+921
| +501% | +$43.3K | 0.01% | 184 |
|
|
2019
Q3 | $8K | Sell |
184
-247
| -57% | -$10.7K | ﹤0.01% | 238 |
|
|
2019
Q2 | $17K | Buy |
+431
| New | +$17K | 0.01% | 211 |
|